Literature DB >> 19194773

Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.

Kishiko Nakajima1, Ken-Ichi Umino, Yoshiaki Azuma, Seiichi Kosaka, Kazue Takano, Takao Obara, Kanji Sato.   

Abstract

The pathogenesis of primary hyperparathyroidism (I degrees -HPT) and secondary hyperparathyroidism (II degrees -HPT) remains to be elucidated. To characterize their pathophysiology, we investigated the effects of calcium and phosphate on cell proliferation and PTH release in an organ culture of parathyroid tissues. Dissected parathyroid tissues obtained from patients with I degrees -HPT (adenoma) or II degrees -HPT (nodular hyperplasia) were precultured on a collagen-coated membrane for 1-4 week. After changing the medium for one containing various concentrations of phosphate, PTH release and [(3)H]thymidine incorporation were studied. In contrast to dispersed parathyroid cells cultured in a monolayer, calcium decreased PTH release in a concentration-dependent manner in parathyroid tissues. Furthermore, when parathyroid tissues obtained from II degrees -HPT were precultured for 1-4 weeks, PTH release and parathyroid cell proliferation were significantly increased in high-phosphate medium. These phosphate effects were also observed to a lesser extent in parathyroid tissues obtained from I degrees -HPT, but there was no significant difference between I degrees -HPT and II degrees -HPT. Microarray analyses revealed that mRNA levels of PTH, CaSR, and VDR were well preserved, and several growth factors (e.g. TGF-beta1-induced protein) were abundantly expressed in II degrees -HPT. Using organ cultures of hyperparathyroid tissues, in which PTH release and CaSR are well preserved for a prolonged period, we have demonstrated that phosphate stimulates parathyroid cell proliferation not only in II degrees -HPT but also in I degrees -HPT. Although the mechanism responsible for phosphate-induced cell proliferation remains to be elucidated, our in vitro findings suggest that both parathyroid tissues preserve to some extent a physiological response system to hyperphosphatemia as observed in normal parathyroid cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194773     DOI: 10.1007/s00774-008-0032-8

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  37 in total

1.  Immunohistochemical investigation of angiogenic factors in parathyroid proliferative lesions.

Authors:  Andreas C Lazaris; Sofia Tseleni-Balafouta; Thomas Papathomas; Theodore Brousalis; Georgia Thomopoulou; George Agrogiannis; Efstratios S Patsouris
Journal:  Eur J Endocrinol       Date:  2006-06       Impact factor: 6.664

2.  Up-regulation of the gene encoding protein kinase A type I alpha regulatory subunit in nodular hyperplasia of parathyroid glands in patients with chronic renal failure.

Authors:  Yatsuka Hibi; Fukushi Kambe; Yoshihiro Tominaga; Yutaka Mizuno; Hironobu Kobayashi; Katsumi Iwase; Tsuneo Imai; Hisao Seo
Journal:  J Clin Endocrinol Metab       Date:  2005-11-22       Impact factor: 5.958

3.  Differentiation of human parathyroid cells in culture.

Authors:  W Liu; P Ridefelt; G Akerström; P Hellman
Journal:  J Endocrinol       Date:  2001-03       Impact factor: 4.286

Review 4.  Vitamin D and retinoids in parathyroid glands (review).

Authors:  P Hellman; W Liu; G Westin; H Törmä; G Akerström
Journal:  Int J Mol Med       Date:  1999-04       Impact factor: 4.101

5.  Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.

Authors:  F Cetani; A Picone; P Cerrai; E Vignali; S Borsari; E Pardi; P Viacava; A G Naccarato; P Miccoli; O Kifor; E M Brown; A Pinchera; C Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

6.  Genomic characterization and embryonic expression of the mouse Bigh3 (Tgfbi) gene.

Authors:  D F Schorderet; M Menasche; S Morand; S Bonnel; V Büchillier; D Marchant; K Auderset; C Bonny; M Abitbol; F L Munier
Journal:  Biochem Biophys Res Commun       Date:  2000-08-02       Impact factor: 3.575

7.  Effect of calcium and magnesium on deoxyribonucleic acid synthesis in rat parathyroid glands in vitro.

Authors:  M J Lee; S I Roth
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

8.  alpha-Klotho as a regulator of calcium homeostasis.

Authors:  Akihiro Imura; Yoshihito Tsuji; Miyahiko Murata; Ryota Maeda; Koji Kubota; Akiko Iwano; Chikashi Obuse; Kazuya Togashi; Makoto Tominaga; Naoko Kita; Ken-ichi Tomiyama; Junko Iijima; Yoko Nabeshima; Makio Fujioka; Ryo Asato; Shinzo Tanaka; Ken Kojima; Juichi Ito; Kazuhiko Nozaki; Nobuo Hashimoto; Tetsufumi Ito; Takeshi Nishio; Takashi Uchiyama; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

9.  Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.

Authors:  N Garcia de la Torre; I Buley; J A H Wass; D G Jackson; H E Turner
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  A catalogue of gene expression in the developing kidney.

Authors:  Kristopher Schwab; Larry T Patterson; Bruce J Aronow; Ruth Luckas; Hung-Chi Liang; S Steven Potter
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

View more
  3 in total

Review 1.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05

Review 2.  Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.

Authors:  Mario Cozzolino; Andrea Galassi; Ferruccio Conte; Michela Mangano; Luca Di Lullo; Antonio Bellasi
Journal:  Ther Clin Risk Manag       Date:  2017-06-01       Impact factor: 2.423

Review 3.  Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy.

Authors:  Claudia Friedl; Emanuel Zitt
Journal:  Drug Des Devel Ther       Date:  2018-06-01       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.